合同研究公司艾昆纬（IQVIA）今日盘中大涨12.86%，引起市场广泛关注。
这一显著涨幅主要源于公司公布的第二季度业绩超出华尔街预期。艾昆纬报告称，第二季度调整后每股收益为2.81美元，高于分析师平均预期的2.77美元。同时，公司季度总收入增长5.3%，达到40.2亿美元，超过了分析师平均预期的39.6亿美元。
艾昆纬的技术和分析部门表现尤为突出，季度销售额达16.3亿美元，高于预期的16亿美元。这主要得益于医疗保健数据和分析服务需求的上升，以及美国食品和药物管理局（FDA）药品批准量的增加。尽管面临制药业可能征收高额关税等挑战，公司仍然维持了较为稳健的年度展望。艾昆纬预计全年调整后每股收益在11.75美元至12.05美元之间，年收入预期在161亿美元到163亿美元之间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.